- AVF Academy
- Intermediate-Risk PE
- Identifying the More Vulnerable Patient in Acute Pulmonary Embolism
Robert Attaran, MDMember, AVF Newsletter Committee
Associate Professor Cardiovascular Medicine, Yale University
The presentation of pulmonary embolism (PE) ranges from an incidental finding on imaging to sudden cardiac arrest. The most critical stage is within the first 72 hours, particularly the first 24 hours. Because outcomes vary so widely, the 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM guidelines on acute PE introduce a five-tier clinical classification, A through E, designed to match risk assessment with management.1
Category B patients are symptomatic, but do not possess high risk criteria (eg, simplified pulmonary embolism severity index [sPESI] is 0 and the right ventricle [RV] is not enlarged). Category C patients possess high risk criteria (eg, sPESI ⩾ 1, elevated troponin or B-type natriuretic peptitde (BNP), RV enlargement, need for supplementary oxygen). Category D patients (those with incipient cardiac failure) may demonstrate normotensive shock or transient hypotension. Category D patients may have signs of end-organ damage such as acute kidney injury or lactic acidosis.
The 2026 Guidelines recommend the following for class C or greater PE: measurement of 1 or more biomarker, lactate, RV size and function, and PERT team assessment. Category D patients must be evaluated for normotensive shock (eg, via right heart catheterization).
While the PESI, sPESI, and Hestia risk scores can identify low-risk patients (ie, those who can be discharged), they do not perform well in predicting clinical deterioration. PE risk scores, of which there are several, were developed based on characteristics and factors measured at diagnosis or presentation. Scores such as those based on vital signs allow for them to be repeated over time. The NEWS (National Early Warning Score), NEWS2, Bova, and composite pulmonary embolism shock (CPES) scores can be utilized to estimate the likelihood of normotensive shock and higher-at-risk patients.
An elevated serum lactate level is associated with 5-fold greater mortality risk even in normotensive PE patients. This makes checking serial serum lactate levels a simple tool. A mean arterial pressure of < 80mmHg is also a higher risk finding and may be used for following at-risk patients. Another tool may be urine output monitoring. Last but not least, the PERT team may also participate in longitudinal follow-up.
References:
- Creager MA, et al. 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026 Mar 24;153(12):e977-e1051.. Erratum in: Circulation. 2026 Jul 14;154(2):e24
Related
Venous Early Career Course (VECC) 2026: Live Patients, Cases, and Procedure... Venous Early Career Course (VECC) 2026: Live Patients, Cases, and Procedures (Attendee Access)
Venous Early Career Course (VECC) 2026: Live Patients, Cases, and Procedure... Venous Early Career Course (VECC) 2026: Live Patients, Cases, and Procedures
- Members
- $0.00 USD
- Non-Members
- $99.00 USD



